950160 Stock Chart & Stats
₩14560.00
-₩1,350.00(-8.49%)
―
--
Day’s Range― - ―
52-Week Range₩13,880.00 - ₩149,000.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)401.61K
Market Cap
₩1.35T
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.69
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding424,850,800
10 Day Avg. Volume508,727
30 Day Avg. Volume401,611
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-412,628.49
Revenue Forecast (FY)₩11.75T
950160 FAQ
What was Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh’s price range in the past 12 months?
Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh lowest stock price was ₩13880.00 and its highest was ₩149000.00 in the past 12 months.
What is Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh’s market cap?
Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh’s market cap is ₩1.35T.
When is Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh’s earnings last quarter?
Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh released its earnings results on May 15, 2026. The company reported -₩1197.268 earnings per share for the quarter, missing the consensus estimate of N/A by -₩1197.268.
Is Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh overvalued?
According to Wall Street analysts Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh’s price is currently Undervalued.
Does Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh pay dividends?
Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh does not currently pay dividends.
What is Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh’s EPS estimate?
Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh have?
Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh has 424,850,800 shares outstanding.
What happened to Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh’s price movement after its last earnings report?
Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh reported an EPS of -₩1197.268 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.362%.
Which hedge fund is a major shareholder of Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh?
Currently, no hedge funds are holding shares in KR:950160
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh (950160) Earnings & Revenues
Hanmi Science Co., Ltd
―
Celltrion Pharm Inc.
―
OliX Pharmaceuticals, Inc.
―
ABL Bio, Inc.
―
SK bioscience Co.,Ltd.
―